RB1 and malignant peripheral nerve sheath tumor: Since most MPNSTs lack CDKN2A because of early genomic deletion of the locus in pre-malignant lesions, the de-repression of CCND1 and CCNE1 upon PRC2 loss would be expected to drive MPNST progression by abolishing RB1 activity.